John Petery, DPM
Primary Podiatric Medicine · Greensboro, NCNPI 1811946965
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Paratek Pharmaceuticals, Inc. at 35.3% of the total. Reporting peaked in 2023 at $527 and has fallen 54.1% since, to $242 in 2025.
Across 198 payments — averaging $13.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$947
- Amgen$603
- Smith+Nephew$220
- Zyla Life Sciences, Inc.$163
- Organogenesis Inc.$94
- Vertex$90
- plus $566 from 17 others
What the payments were for
- Food & beverage$2,677100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 60 | $947 |
| Amgen(2 entities) | 60 | $603 |
| Smith+Nephew | 13 | $220 |
| Zyla Life Sciences, Inc. | 28 | $163 |
| Organogenesis Inc. | 4 | $94 |
| Vertex | 4 | $90 |
| Radius Health, Inc. | 2 | $56 |
| GRT US Holding, Inc. | 2 | $55 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $55 |
| ANI Pharmaceuticals, Inc. | 2 | $49 |
| Nabriva Therapeutics, PLC | 4 | $48 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $40 |
| Melinta Therapeutics, LLC | 2 | $37 |
| Nevro Corp. | 2 | $34 |
| DJO, LLC | 2 | $30 |
| Zimmer Biomet | 2 | $26 |
| Medtronic | 1 | $25 |
| Triad Life Sciences Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $24 |
| Averitas Pharma Inc. | 1 | $22 |
| Sebela Pharmaceuticals Inc. | 1 | $18 |
| Merck | 1 | $13 |
| Sandoz | 1 | $12 |
How this compares
$2,682 in reported general payments places this provider in the 70th percentile of 64 primary podiatric medicine providers in North Carolina.
See all primary podiatric medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 70 | $1,144 |
| Ketoconazole | 29 | $862 |
| Colchicine | 14 | $672 |
| Terbinafine Hcl | 74 | $645 |
| Mupirocin | 45 | $331 |
| Allopurinol | 35 | $169 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $148 |
| Prednisone | 34 | $138 |
| Cephalexin | 14 | $106 |
| Naproxen | 21 | $71 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Greensboro
- Clark BrackneyGreensboro$7K
- Martha AjlounyGreensboro$3K
- Ashma DavidsonStatesville$32K
- Joseph KiblerSupply$23K
- Jacob PaniciCary$13K
- Ythan WebsterNew Bern$10K
- Jon StancilGreenville$9K
- Kevin McDonaldConcord$8K
- Eric WardMatthews$7K
- Amy PitzerGreenville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.